BioSpace News Archive

1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the fourth quarter and full year ended December 31, 2019.

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Dicerna’s DCR-A1AT for the treatment of alpha-1 antitrypsin (A1AT) deficiency

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and full year 2019 financial results.

Cigna Corporation announced the pricing terms of its previously announced offers to purchase for cash up to $500,000,000 of Cigna Holding Company’s 4.000% Senior Notes due 2022

Protecting the health and safety of our staff and their families is of paramount concern to the U.S. Food and Drug Administration.

Afya Limited, or Afya, announced that it has hired Luis André Blanco and will assume the position of Chief Financial Officer effective as of April 20, 2020.

The test will be used on the company’s m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

Direct Relief this week is shipping 250,000 N95 masks and other personal protective equipment to as many as 1,000 community health centers and free clinics in all 50 U.S.

Medtronic plc announced that it will more than double its capacity to manufacture and supply ventilators, in response to the urgent needs of patients and healthcare system across the globe as we confront the COVID-19 virus.

Medtronic plc, the global leader in medical technology, continues to make progress in increasing ventilator production worldwide.